Reconstruction of an active SOCS3-based E3 ubiquitin ligase complex in vitro: identification of the active components and JAK2 and gp130 as substrates
- Author(s)
- Kershaw, NJ; Laktyushin, A; Nicola, NA; Babon, JJ;
- Details
- Publication Year 2014-01-20,Volume 32,Issue #1,Page 1-10
- Journal Title
- Growth factors
- Publication Type
- Journal Article
- Abstract
- Abstract SOCS3 (suppressor of cytokine signaling 3) inhibits the intracellular signaling cascade initiated by exposure of cells to cytokines. SOCS3 regulates signaling via two distinct mechanisms: directly inhibiting the catalytic activity of Janus kinases (JAKs) that initiate the intracellular signaling cascade and catalysing the ubiquitination of signaling components by recruiting components of an E3 ubiquitin ligase complex. Here we investigate the latter mode-of-action biochemically by reconstructing a SOCS3-based E3 ubiquitin ligase complex in vitro using fully purified, recombinant components and examining its ability to promote the ubiquitination of molecules involved in the cytokine signaling cascade. We show that SOCS3 is an active substrate recruitment module for a Cullin5-based E3 ligase and have defined the core protein components required for ubiquitination. SOCS3-induced polyubiquitination was rapid and could proceed through a number of different ubiquitin lysines. SOCS3 catalyzed the ubiquitination of both the IL-6 receptor common chain (gp130) and JAK2.
- Publisher
- Informa
- Keywords
- Cullin5, cytokine receptor, cytokine signaling, E3 ubiquitin ligase, JAK, suppressor of cytokine signaling, SOCS3, ubiquitination
- Research Division(s)
- Cancer And Haematology; Structural Biology
- Publisher's Version
- https://doi.org/10.3109/08977194.2013.877005
- NHMRC Grants
- NHMRC/461219, NHMRC/487922, NHMRC/1011804,
- Terms of Use/Rights Notice
- Copyright © 2014 Informa Plc. All rights reserved.
Creation Date: 2014-01-24 12:02:22